Suppr超能文献

[遗传性肌张力障碍的分子生物学]

[Molecular biology of hereditary dystonia].

作者信息

Nagatsu T, Ichinose H

机构信息

Division of Molecular Genetics II Neurochemistry, School of Medicine, Fujita Health University, Aichi.

出版信息

No To Hattatsu. 1998 Mar;30(2):93-100.

PMID:9545771
Abstract

The causative genes of hereditary dystonia (hereditary progressive dystonia, HPD; dopa-responsive dystonia, DRD) were discovered in 1994-1995. HPD/DRD is caused by the deficiency of dopamine to less than 20% of the normal level in the nigro-striatum of the brain owing to the mutations of the dopamine synthesizing enzymes. Autosomal dominant dystonia (Segawa's disease) was found to be caused by mutations of GTP cyclohydrolase I which synthesizes tetrahydrobiopterin, the cofactor of tyrosine hydroxylase, by Ichinose et al. (Nature Genetics, 1994) in Japan. Autosomal recessive dystonia was reported to be caused by mutations of tyrosine hydroxylase by Lüdecke et al. (Human Genetics, 1995) in Germany. Hereditary dystonia, especially autosomal dominant Segawa's disease can be completely controlled by L-dopa administration. Measurement of the activity of GTP cyclohydrolase I in mononuclear blood cells is useful for the diagnosis of Segawa's disease.

摘要

遗传性肌张力障碍(遗传性进行性肌张力障碍,HPD;多巴反应性肌张力障碍,DRD)的致病基因于1994年至1995年被发现。HPD/DRD是由于多巴胺合成酶的突变导致大脑黑质纹状体中多巴胺缺乏至正常水平的20%以下所致。日本的市野等人(《自然遗传学》,1994年)发现常染色体显性肌张力障碍(Segawa病)是由合成四氢生物蝶呤(酪氨酸羟化酶的辅因子)的GTP环化水解酶I的突变引起的。德国的吕德克等人(《人类遗传学》,1995年)报道常染色体隐性肌张力障碍是由酪氨酸羟化酶的突变引起的。遗传性肌张力障碍,尤其是常染色体显性Segawa病,可通过服用左旋多巴得到完全控制。检测单核血细胞中GTP环化水解酶I的活性有助于Segawa病的诊断。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验